For UK Healthcare Professionals only.
The 1^st Immundeficiency Faculty Meeting is organised and funded by Grifols. Grifols products will be discussed at this meeting.

1^st Immunodeficiency Faculty Meeting:
Consequences of modern targeted immunotherapy – a cross-disciplinary webinar

Thursday, 27^th November 2025
17:00 - 19:00

Click here to register

Agenda

17:00

Welcome and introductions
Dr Duncan Stacey
Associate director of Medical Affairs, Grifols UK

17:10

Immunomodulation on the rise: emerging therapies and the secondary immunodeficiency challenge
Dr Patrick Yong
Consultant clinical immunologist, Frimley Health NHS Foundation Trust

17:35

CAR-T in practice: a haematologist’s guide from referral to recovery
Dr Eleni Tholouli
Consultant haematologist, director of Cellular and Gene Therapies Unit, Manchester Royal Infirmary

18:00

Immunomodulation in neurology: therapeutic strategies and clinical insights
Dr Amy Davidson
Consultant neurologist, Queen Elizabeth University Hospital, Glasgow

18.25

Chronic infection as a complication of CAR-T cell therapy
Dr Sorena Kiani
Consultant clinical immunologist, Royal Free London NHS Foundation Trust

18:50

Final remarks and close
Dr Duncan Stacey
Associate director of Medical Affairs, Grifols UK

(All talks are 20-minute talks with 5 minutes for discussion and case studies)

CPD accreditation to be applied for

Register

By registering, you will be provided with further information about commercial, scientific and promotional communications related to Grifols products, activities and services.

First name

Last name

Email address – please provide an approved NHS email address or we will not be able to share the link to join the webinar

Hospital/Institution

Country of practice

Professional Position

Service/Department

Data Protection Information: Grifols International, S.A. as data controller, will process your personal data to send you commercial, scientific or educational information about the Grifols’ group, its products, services and activities. Legal basis: consent of the data subject. Recipients: Grifols’ group companies and service providers. Rights: to access, rectify and erase personal data, as well as other rights detailed in the additional information section. For additional information on how Grifols processes your personal data please click here.

By signing up, you agree to receive commercial, scientific, and promotional communications related to Grifols' products, activities and services in accordance with the terms and conditions and privacy policy.

This information is aimed exclusively at authorised healthcare professionals in the UK.Can you please confirm that you are a healthcare professional practising in the UK?

Register

This information is aimed exclusively at authorised healthcare professionals in the UK.

Can you please confirm that you are a healthcare professional practising in the UK?